Jim Simons's position in Astrazeneca plc is currently worth $107M. That's 0.14% of their equity portfolio (155th largest holding). The first Astrazeneca plc trade was made in Q2 2013. Since then Jim Simons bought shares 21 more times and sold shares on 27 occasions. The stake costed the investor $72.6M, netting the investor a gain of 47% so far.
Renaissance Technologies LLC grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN) by 967.2% during the 2nd quarter, according to its most recent 13F fili...